2015
DOI: 10.5222/iksst.2015.013
|View full text |Cite
|
Sign up to set email alerts
|

Kronik Ürtikerli Olgularda Hepatit B ve Hepatit C Sıklığının Değerlendirilmesi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…In the study performed by İnci and Günaydın, 56 chronic urticaria cases were examined, 21 patients had anti-HBs positivity and 2 patients had HBsAg positivity. However, none of the patients had anti-HCV positivity (Inci and Gunaydın, 2015). Anti-HCV antibody positivity was found in 4 of 55 chronic urticaria patients in the study of Arinkal et al (Arinkal et al, 2001).…”
Section: Discussionmentioning
confidence: 89%
See 3 more Smart Citations
“…In the study performed by İnci and Günaydın, 56 chronic urticaria cases were examined, 21 patients had anti-HBs positivity and 2 patients had HBsAg positivity. However, none of the patients had anti-HCV positivity (Inci and Gunaydın, 2015). Anti-HCV antibody positivity was found in 4 of 55 chronic urticaria patients in the study of Arinkal et al (Arinkal et al, 2001).…”
Section: Discussionmentioning
confidence: 89%
“…In recent years, it has been suggested that viral hepatitis may be associated with many other autoimmune diseases such as mixed cryoglobulinemia, polyarteritis nodosa and Sjögren syndrome, other than liver findings. In addition, hepatitis C virus can be associated with many dermatological diseases such as pruritus, porphyria kutanea tarda, vasculitis, salivary gland lesions, lichen planus, necrolitic acral erythema (Balik, 1994a;Çakaloğlu, 1994b;Gül and Çevik, 1998;Bilen et al, 1999;Oztas et al, 2007;Inci and Gunaydın, 2015).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[8,9] In recent studies conducted in Turkey, HBsAg seroprevalence was found between 0.3-4.0%, and Anti-HCV seroprevalence between 0.3-1.3%, respectively. [3,[10][11][12][13][14][15][16] HBsAg and Anti-HCV seroprevalence was 2.5% and 0.9% in oncology patients and 1.0% and 0.8% in patients admitted at the outpatient clinics of family physicians in a tertiary care hospital in Karabük. [4,7] HBsAg and Anti-HCV reactivities were 1.5% and 0.1% in the preoperative evaluation of the patients in a private hospital in Van.…”
Section: Discussionmentioning
confidence: 99%